{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:27:57Z","timestamp":1759624077243,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejogrb.2021.10.002","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T17:32:16Z","timestamp":1633627936000},"page":"36-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effects of the implementation of second-line prenatal cell-free DNA testing on termination of pregnancy in a French perinatal network"],"prefix":"10.1016","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0131-3167","authenticated-orcid":false,"given":"Cl\u00e9mence","family":"Duvillier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolphe","family":"Dard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9r\u00e9nice","family":"Herv\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5774-2756","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Vialard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaud","family":"Quibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2021.10.002_b0005","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. 2017. https:\/\/www.has-sante.fr\/portail\/jcms\/c_2768535\/fr\/trisomie-21-la-has-actualise-ses-recommandations-concernant-le-depistage-prenatal-de-la-trisomie-21."},{"issue":"9","key":"10.1016\/j.ejogrb.2021.10.002_b0010","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/humrep\/den224","article-title":"Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free -hCG and pregnancy-associated plasma protein-A","volume":"23","author":"Kagan","year":"2008","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.ejogrb.2021.10.002_b0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.gyobfe.2007.02.004","article-title":"Screening for Down Syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population","volume":"35","author":"Rozenberg","year":"2007","journal-title":"Gyn\u00e9col Obst\u00e9trique Fertilit\u00e9"},{"issue":"6","key":"10.1016\/j.ejogrb.2021.10.002_b0020","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/uog.17283","article-title":"Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13: First-trimester combined screening for trisomies 21, 18 and 13","volume":"49","author":"Santorum","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.10.002_b0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ajmg.c.30119","article-title":"Aneuploidy screening in the first trimester","volume":"145C","author":"Spencer","year":"2007","journal-title":"Am J Med Genetics Part C: Semin Med Genetics"},{"issue":"6","key":"10.1016\/j.ejogrb.2021.10.002_b0040","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/pd.4092","article-title":"Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population: Clinical experience of NIPT","volume":"33","author":"Fairbrother","year":"2013","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.10.002_b0045","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/uog.17484","article-title":"Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis: Cell-free DNA in screening for aneuploidies","volume":"50","author":"Gil","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2021.10.002_b0050","unstructured":"Superior Health Council. https:\/\/www.health.belgium.be\/sites\/default\/files\/uploads\/fields\/fpshealth_theme_file\/19095725.pdf Accessed May 28,2020."},{"issue":"4","key":"10.1016\/j.ejogrb.2021.10.002_b0055","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/01.AOG.0000116260.81570.60","article-title":"Risk factors for legal induced abortion\u2013related mortality in the United States","volume":"103","author":"Bartlett","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.10.002_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.10.031","article-title":"Trends in gestational age at time of surgical abortion for fetal aneuploidy and structural abnormalities","volume":"216","author":"Davis","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.10.002_b0065","first-page":"121","article-title":"\u00c9valuation de la morbidit\u00e9 maternelle apr\u00e8s interruption m\u00e9dicamenteuse de grossesse \u00e0 partir de 12 semaines d\u2019am\u00e9norrh\u00e9e","volume":"3","author":"Guillem","year":"2004","journal-title":"J Gyn\u00e9col Obst\u00e9trique et Biol Reprod"},{"key":"10.1016\/j.ejogrb.2021.10.002_b0070","unstructured":"Lemon J, Grosjean P (2015). prettyR: Pretty Descriptive Stats. R package version 2.2. https:\/\/CRAN.R-project.org\/package=prettyR."},{"issue":"4","key":"10.1016\/j.ejogrb.2021.10.002_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.06.008","article-title":"Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities","volume":"213","author":"Hume","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ejogrb.2021.10.002_b0080","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/pd.5050","article-title":"The influence of noninvasive prenatal testing on gestational age at time of abortion for aneuploidy: Effect of NIPT on abortion for aneuploidy","volume":"37","author":"Lassey","year":"2017","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ejogrb.2021.10.002_b0085","unstructured":"French Agency of Biomedicine. https:\/\/www.agence-biomedecine.fr\/annexes\/bilan2016\/donnees\/diag-prenat\/02-centres\/pdf\/cpdpn.pdf."},{"key":"10.1016\/j.ejogrb.2021.10.002_b0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejogrb.2014.08.028","article-title":"The consequences of implementing non-invasive prenatal testing in Dutch national health care: A cost-effectiveness analysis","volume":"182","author":"Beulen","year":"2014","journal-title":"Eur J Obstetrics Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2021.10.002_b0095","doi-asserted-by":"crossref","unstructured":"Chitty LS, Wright D, Hill M, Verhoef TI, Daley R, Lewis C, et al. Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down\u2019s syndrome into NHS maternity care: Prospective cohort study in eight diverse maternity units. BMJ. 2016 Jul 4;i3426.","DOI":"10.1136\/bmj.i3426"},{"issue":"10","key":"10.1016\/j.ejogrb.2021.10.002_b0100","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/pd.4601","article-title":"Overview of the impact of noninvasive prenatal testing on diagnostic procedures: Impact of NIPT on diagnostic procedures","volume":"35","author":"Warsof","year":"2015","journal-title":"Prenat Diagn"},{"issue":"13","key":"10.1016\/j.ejogrb.2021.10.002_b0105","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/pd.5182","article-title":"Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome?","volume":"37","author":"Hill","year":"2017","journal-title":"Prenat Diagn"},{"issue":"6","key":"10.1016\/j.ejogrb.2021.10.002_b0115","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/pd.4125","article-title":"Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening: NIPT uptake in PNS positive women","volume":"33","author":"Chetty","year":"2013","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.10.002_b0120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.gofs.2017.01.015","article-title":"Analysis of prenatal follow-up strategies for trisomy 21 affected pregnancies in France","volume":"45","author":"Dupont","year":"2017","journal-title":"Gyn\u00e9col Obst\u00e9trique Fertilit\u00e9 S\u00e9nologie"},{"key":"10.1016\/j.ejogrb.2021.10.002_b0125","unstructured":"Khoshnood B, Lelong N, Lecourbe A, Ballon M, Goffinet F, Port-Royal M. Registre des malformations cong\u00e9nitales de Paris. Surveillance \u00e9pid\u00e9miologique et diagnostic pr\u00e9natal des malformations: \u00e9volution sur 35 ans :1981\u20132014."},{"issue":"1","key":"10.1016\/j.ejogrb.2021.10.002_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.04.005","article-title":"Utilization of noninvasive prenatal testing: impact on referrals for diagnostic testing","volume":"213","author":"Williams","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.10.002_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcu.22243","article-title":"Noninvasive prenatal testing: Impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection: NIPT in clinical practice","volume":"43","author":"Wax","year":"2015","journal-title":"J Clin Ultrasound"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521004917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521004917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:53:34Z","timestamp":1759557214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211521004917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":24,"alternative-id":["S0301211521004917"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.10.002","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the implementation of second-line prenatal cell-free DNA testing on termination of pregnancy in a French perinatal network","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}